SoundHound AI Reports Record Third Quarter, Revenue Increases to $13.3 Million, Adjusted EBITDA Improves 57% Year Over Year
SANTA CLARA, Calif.–(BUSINESS WIRE)–SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today reported its financial... Read more.
Intellinetics to Showcase Payables Automation Solution at Constellation HomeBuilder Systems’ Build Smarter 2023 Conference
Leverages Artificial Intelligence and Integration Capabilities COLUMBUS, Ohio–(BUSINESS WIRE)–Intellinetics, Inc. (NYSE American: INLX), a digital transformation... Read more.
AEye Reports Third Quarter 2023 Results
Provides Update on Automotive-First Strategy Significant Reduction in Burn Rate Extending Cash Runway out to 2025 DUBLIN, Calif.–(BUSINESS WIRE)–AEye,... Read more.
DISCO Announces Third Quarter 2023 Financial Results
Total Revenue of $34.9 Million, A Year over Year Increase of 1% AUSTIN, Texas–(BUSINESS WIRE)–CS Disco, Inc. (“DISCO”) (NYSE: LAW) today announced... Read more.
REPAY Reports Third Quarter 2023 Financial Results
Raising Full Year 2023 Revenue Outlook Gross Profit Growth of 3% in Q3 and 7% Year-to-Date Normalized Organic Gross Profit Growth1 of 12% in Q3 and 13% Year-to-Date... Read more.
H&E Equipment Services Reports Quarterly Cash Dividend
BATON ROUGE, La.–(BUSINESS WIRE)–$HEES–H&E Equipment Services, Inc. (NASDAQ: HEES) today announced that its Board of Directors declared a regular... Read more.
HEI Reports Third Quarter 2023 Results
3Q23 Net Income of $41.1M and Diluted Earnings Per Share (EPS) of $0.37 $27.6M of Pre-tax Maui Wildfire-Related Expenses Core Businesses Performing Well Solid Credit... Read more.
Comstock Reports Third Quarter 2023 Results
Revenue increased for the 13th consecutive quarter to $14.5 million; YTD revenue of $33.7 million, up 12% vs. prior year Net income increased 27% to $4.7 million;... Read more.
Creativ Strategies Appoints Sara Yazdani as Director of Media & Entertainment PR
LOS ANGELES–(BUSINESS WIRE)–Creativ Strategies has appointed Sara Yazdani as Director of Media & Entertainment PR. In her new role, Sara is responsible... Read more.
Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms Takeda Continues 70-plus Year Legacy... Read more.